BioTuesdays

Category - Markets

Zosano Logo
Markets

BTIG cuts Zosano Pharma PT to $2 from $7

BTIG slashed the price target for Zosano Pharma (NASDAQ:ZSAN) to $2 from $7, citing a complete response letter about the NDA for Qtrypta, a transdermal microneedle system form of zolmitriptan in development for acute...

October 22, 2020
Orthofix Logo
Markets

Stifel starts Orthofix Medical at buy; PT $39

Stifel launched coverage of Orthofix Medical (NASDAQ:OFIX) with a “buy” rating and price target of $39. The stock closed at $34.05 on Oct. 19. Orthofix is focused on providing medical devices, operating through the...

October 19, 2020
Alphatec Spine Logo
Markets

Stifel starts Alphatec at buy; PT $13

Stifel initiated coverage of Alphatec Holdings (NASDAQ:ATEC) with a “buy” rating and $13 price target. The stock closed at $9.88 on Oct. 19. Alphatec engages in design, development, and marketing of spinal fusion...

October 19, 2020
SeaSpine Holdings
Markets

Stifel starts SeaSpine at buy; PT $22

Stifel launched coverage of SeaSpine Holdings (NASDAQ:SPNE) with a “buy” rating and price target of $22. The stock closed at $14.97 on Oct. 19. “After several years of uneven performance post the 2015 spin-out from...

October 19, 2020
Celldex Therapeutics Logo
Markets

HCW ups Celldex Therapeutics PT to $25 from $16

H.C Wainwright raised its price target for Celldex Therapeutics (NASDAQ:CLDX) to $25 from $16, citing three differentiated programs that are now in the clinic. The stock closed at $15.76 on Oct. 16. “As we have stated...

October 19, 2020
Vericel Logo
Markets

BTIG ups Vericel PT to $30 from $23

BTIG raised its price target for Vericel (NASDAQ:VCEL) to $30 from $23 after an analyst and investor event focused primarily on NexoBrid, a recently licensed burn enzymatic debridement product from MediWound. ...

October 19, 2020
Plus Therapeutics Logo
Markets

Maxim starts Plus Therapeutics at buy; PT $6

Maxim Group launched coverage of Plus Therapeutics (NASDAQ:PSTV) with a “buy” rating and price target of $6. The stock closed at $2.56 on Oct. 15. The company’s lead asset, rhenium nanoliposome (RNL), is being developed...

October 16, 2020
Aldeyra-Therapeutics
Markets

BTIG starts Aldeyra Therapeutics at buy; PT $29

BTIG initiated coverage of Aldeyra Therapeutics (NASDAQ:ALDX) with a “buy” rating and $29 price target. The stock closed at $6.86 on Oct. 15. Aldeyra is targeting reactive aldehyde species (RASP) for a range of...

October 16, 2020
InspireMD
Markets

AGP starts InspireMD at buy; PT 70 cents

Alliance Global Partners initiated coverage of InspireMD (NYSE American:NSPR) with a “buy” rating and price target of 70 cents. The stock closed at 32 cent on Oct. 15. InspireMD has developed the CGuard EPS (Embolic...

October 16, 2020
Cogent Biosciences Logo
Markets

Ladenburg starts Cogent Biosciences at buy; PT $4

Ladenburg Thalmann launched coverage of Cogent Biosciences (NASDAQ:COGT) with a “buy” rating and $4 price target. The stock closed at $2.89 on Oct. 13. Cogent has a late-stage clinical asset, CGT9486, in development for...

October 14, 2020